Global pharmaceutical giant GlaxoSmithKline has invested $11m in expanding its Sri Lankan operations.
The investment will be welcomed by the government and its struggling economy.
Sri Lanka is facing difficulties in financing the upkeep of its military, proportionally one of the largest in the world.
A significant part of its national budget is dedicated to the defence ministry, headed by war crimes accused Gothabaya Rajapakse.
In a media statement, T. S. Dayanand, Managing Director of GSK Consumer Healthcare said, “Over the years, we have consistently invested in the Sri Lankan business. This new investment will enable us to bring more new products to our consumers. It will also help us localise more of our products and reduce dependence on imports.” reported The Sunday Times.
Every little kills... in Sri Lanka (12 Dec 2012)
Boycott, divestments and sanctions call against Sri Lanka (07 Sep 2012)